Wu Xiaoping

Dr. Wu Xiaoping is a senior patent counsel at Wanhuida Intellectual Property. She has handled a substantial number of patent prosecution, invalidation, administrative, and infringement litigation cases. Xiaoping has profound understanding of the substance of China’s Patent Law and deep technical expertise in chemical engineering, inorganic/organic chemical engineering, and organic chemistry.

She successfully defended the validity of the patent concerning the formulation of amlodipine and irbesartan compound preparation in Simcere v Patent Re-examination Board (the predecessor of the Patent Re-examination and Invalidation Department of the CNIPA) in the administrative retrial litigation before the Supreme People’s Court (SPC), a case included in the SPC’s Annual Report on Intellectual Property Cases of the Year.

In the past few years, Xiaoping has been honing her skill set in litigating pharmaceutical invention patent disputes and has developed an insight into judicial practice in the pharmaceutical field.